跳至主要内容
临床试验/NCT01798316
NCT01798316终止4 期

IV Acetaminophen for Postoperative Analgesia After Laparoscopic Cholecystectomy

Northwell Health3 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2013年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
105
试验地点
3
主要终点
Number of Participants With Postoperative Nausea and Vomiting (PONV).

研究概览

简要总结

The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain management after laparoscopic cholecystectomy to determine if its use to supplement standard of care pain management decreases the incidence of post-operative nausea and vomiting.

详细描述

The recent clinical development of an intravenous (IV) acetaminophen formulation for use in the US has important implications for the management of postoperative pain given its safety profile and suitability for use in the early phase of the postoperative period. In clinical studies a significant opioid-sparing effect has been documented with a substantial percentage of patients avoiding the need for opioid rescue medication altogether. This avoidance or delay in the use of opioids has been shown to reduce undesirable side effects. It is proposed that the use of IV acetaminophen in the post anesthesia care unit (PACU) for postoperative analgesia after laparoscopic cholecystectomy will result in decreased incidence of post operative nausea and vomiting (PONV) and decreased use of narcotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is undergoing pre-scheduled laparoscopic cholecystectomy;
  • American Society of Anesthesiology patient classification status I-II

排除标准

  • Regular preoperative use of or opioids,
  • Subjects admitted after surgery for postoperative complications other than postoperative pain or PONV.
  • Subjects converted to open laparoscopic cholecystectomy
  • Known allergy/hypersensitivity to acetaminophen
  • Use of opioids prior to commencement of the study (<7 days)
  • Patients with chronic pain conditions or disease requiring pain control
  • Abnormal liver function
  • Known or suspected alcohol, drug or opiate abuse or dependence
  • Patients with a BMI of greater than 35
  • Other physical, mental or medical conditions that could effect participation.
  • Abnormal renal function; serum creatinine>2gm/dl

研究组 & 干预措施

IV Acetaminophen

Active Comparator

IV Acetaminophen administered on admission to post-anesthesia care unit

干预措施: IV Acetaminophen (Drug)

Standard of care

Active Comparator

Standard of care pain management regimen including opioids administered on admission to post-anesthesia care unit

干预措施: Standard of Care (Drug)

结局指标

主要结局

Number of Participants With Postoperative Nausea and Vomiting (PONV).

时间窗: 4 hours plus/minus 30 minutes

Number of participants with postoperative nausea and vomiting (PONV) will be recorded during PACU stay. PONV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching.

次要结局

  • Number of Participants With Post Discharge Nausea and Vomiting (PDNV)(Up to two days following surgery)
  • Highest Pain Intensity Score Using Numeric Rating Scale (NRS)(4 hours plus/minus 30 minutes)
  • Patient Satisfaction on a 5 Point Likert Scale(Up to one week following surgery)
  • Pain Intensity Score 1 Hour Following Surgery Using Numeric Rating Scale(1 hour following surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

IV Acetaminophen for Postoperative Analgesia | 临床试验